Literature DB >> 19500106

Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance.

Yu-Ying Chen1, Zhan-Xiang Wang, Ping-An Chang, Jian-Jun Li, Feng Pan, Li Yang, Zhi-Heng Bian, Lan Zou, Jian-Ming He, Hou-Jie Liang.   

Abstract

Chemotherapy resistance in solid tumors is broad and encompasses diverse unrelated drugs. Three-dimensional multicellular spheroids (MCSs) are a good model for studying in vitro drug resistance. In the current study, we investigated the role of focal adhesion kinase (FAK) in 5-fluorouracil (5-FU) chemoresistance in colon carcinoma MCS culture cells. The expression of FAK was inhibited significantly by specific small hairpin RNA targeting FAK. The suppression of FAK expression did not affect the growth of spheroid cells. However, silencing of FAK combined with 5-FU treatment significantly decreased the 50% inhibitory concentration (IC(50)) of 5-FU and markedly increased the population of apoptosis cells, which was associated with the reduction of the levels of Akt and nuclear factor-kappa B (NF-kappaB). Moreover, knockdown of FAK could inhibit tumor growth and increase the sensitivity of the tumor to 5-FU in the nude mouse xenograft. These results indicate that while not affecting cellular proliferation in the absence of 5-FU, RNA interference targeting FAK potentiated 5-FU-induced cytotoxicity in vitro and in vivo, and partially reversed multicellular resistance, which may contribute to its chemosensitizing effect through efficiently suppressing Akt/NF-kappaB activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500106     DOI: 10.1111/j.1349-7006.2009.01217.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

1.  Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer.

Authors:  Priyanka N Gogate; Elena V Kurenova; Manivannan Ethirajan; Jianqun Liao; Michael Yemma; Arindam Sen; Ravindra K Pandey; William G Cance
Journal:  Cancer Lett       Date:  2014-07-24       Impact factor: 8.679

2.  Digital holography of intracellular dynamics to probe tissue physiology.

Authors:  Daniel Merrill; Ran An; John Turek; David D Nolte
Journal:  Appl Opt       Date:  2015-01-01       Impact factor: 1.980

3.  Cancer cell spheroids as a model to evaluate chemotherapy protocols.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

4.  Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.

Authors:  Jerry E Stewart; Xiaojie Ma; Michael Megison; Hugh Nabers; William G Cance; Elena V Kurenova; Elizabeth A Beierle
Journal:  Mol Carcinog       Date:  2013-07-19       Impact factor: 4.784

5.  Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).

Authors:  Zhaokang Cheng; Laura A DiMichele; Mauricio Rojas; Cyrus Vaziri; Christopher P Mack; Joan M Taylor
Journal:  J Mol Cell Cardiol       Date:  2013-12-14       Impact factor: 5.000

6.  FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells.

Authors:  Kathryn Graham; Kim Moran-Jones; Owen J Sansom; Valerie G Brunton; Margaret C Frame
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 7.  Desmoplasia and chemoresistance in pancreatic cancer.

Authors:  Marvin Schober; Ralf Jesenofsky; Ralf Faissner; Cornelius Weidenauer; Wolfgang Hagmann; Patrick Michl; Rainer L Heuchel; Stephan L Haas; J-Matthias Löhr
Journal:  Cancers (Basel)       Date:  2014-10-21       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.